Call for Proposals HEALTH-2011-two-stage - Cooperation Programme HEALTH-2011-two-stage Closed!
Objectives
The general objetive of the FP7 Cooperation Work Programme in Health-2011 is to improve the health of European citizens and increasing the competitiveness and boost the innovative capacity of European health-related industries while businesses, and addres global health issues including emerging epidemics.
Actions
1.BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH
1.1 HIGH-THROUGHPUT RESEARCH
- HEALTH.2011.1.1-1: SME-targeted research for developing tools and technologies for high-throughput research
- HEALTH.2011.1.1-2: Genome-based biomarkers for patient stratification and pharmacogenomic strategies
1.4 INNOVATIVE THERAPEUTIC APPROACHES AND INTERVENTIONS
- HEALTH.2011.1.4-1: Regenerative medicine clinical trials
- HEALTH.2011.1.4-2: Tools, technologies and devices for application in regenerative medicine.
- HEALTH.2011.1.4-3: Development and production of new, high-affinity protein scaffolds for therapeutic use.
2. TRANSLATING RESEARCH FOR HUMAN HEALTH
2.1. INTEGRATING BIOLOGICAL DATA AND PROCESSES: LARGE-SCALE DATA GATHERING, SYSTEMS BIOLOGY
2.1.1 Large-scale data gathering
- HEALTH.2011.2.1.1-2: Proteins and their interactions in health and disease.
- HEALTH.2011.2.1.1-3: Large-scale genomics approaches to identify host determinants of infectious diseases.
2.2. RESEARCH ON THE BRAIN AND RELATED DISEASES, HUMAN DEVELOPMENT AND AGEING
2.2.1. Brain and brain-related diseases
- HEALTH.2011.2.2.1-1: Investigatordriven clinical trials for childhood-onset neurodegenerative diseases.
- HEALTH.2011.2.2.1-2: Understanding the role of neuroinflammation in neurodegenerative diseases.
- HEALTH.2011.2.2.1-3: Addictive and/or compulsive behaviour in children and adolescents: translating pre-clinical results into therapies.
2.2.2. Human development and ageing
- HEALTH.2011.2.2.2-1: Investigatordriven clinical trials for therapeutic interventions in elderly populations.
- HEALTH.2011.2.2.2-2: Linking human development and ageing.
2.3. TRANSLATIONAL RESEARCH IN MAJOR INFECTIOUS DISEASES: TO CONFRONT MAJOR THREATS TO PUBLIC HEALTH
2.3.1. Anti-microbial drug resistance
- HEALTH.2011.2.3.1-1: Investigatordriven clinical trials of off-patent antibiotics.
- HEALTH.2011.2.3.1-4: Development of multi-analyte diagnostic tests.
- HEALTH.2011.2.3.1-5: Development of tools to control microbial biofilms with relevance to clinical drug resistance.
2.3.3. Potentially new and re-emerging epidemics
- HEALTH.2011.2.3.3-1: Identification of factors promoting the emergence of pathogens with human pandemic potential from pathogens with a zoonotic background and related prevention strategies.
- HEALTH.2011.2.3.3-3: Development of an evidence-based behavioural and communication package to respond to major epidemic outbreaks.
2.4. TRANSLATIONAL RESEARCH IN OTHER MAJOR DISEASES
2.4.1. Cancer
- HEALTH.2011.2.4.1-1: Investigatordriven treatment trials for rare cancers.
- HEALTH.2011.2.4.1-2: Translational research on cancers with poor prognosis.
2.4.2. Cardiovascular diseases
- HEALTH.2011.2.4.2-1: Investigatordriven clinical trials for the management of cardiovascular diseases.
- HEALTH.2011.2.4.2-2: Evaluation and validation studies of clinically useful biomarkers in prevention and management of cardiovascular diseases.
2.4.3. Diabetes and obesity
- HEALTH.2011.2.4.3-1: Investigatordriven clinical trials to reduce diabetes complications.
- HEALTH.2011.2.4.3-2: Development of novel treatment strategies based on knowledge of cellular dysfunction.
- HEALTH.2011.2.4.3-3: Molecular and physiological effects of lifestyle factors on diabetes/obesity.
- HEALTH.2011.2.4.3-4: Genetic and environmental factors in obesity and/or diabetes in specific populations.
3. OPTIMISING THE DELIVERY OF HEALTHCARE TO EUROPEAN CITIZENS
3.3 HEALTH PROMOTION
- HEALTH.2011.3.3-1: Developing methodologies to reduce inequities in the determinants of health.
European community funding
The Community provisional funding available for the call for proposals is:
- 498,00 Million EUR (Annual budget for 2011)
All the important deadlines
- 13 October 2010 - 9 years ago (Deadline for the presentation of proposals)
Further information about the call
Official webpage of the call
Useful documents
Organisations eligible to participate
Opened to the following bodies or institutes with legal status established in the covered areas:
- Any legal organisation
Covered areas
Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:
- European Union (EU)
Directorate-Generale responsible
Directorate-General for Research
Related calls for proposals
- Call for proposals under the Implementation Plan of Fuel Cells and Hydrogen Joint Undertaking - 2014
- 10th Call for Proposals 2014 - Innovative Medicines Initiative
- Joint transnational call for proposals - Safe Implementation of Innovative Nanoscience and Nanotechnology
- 9th Call for Proposals 2013 - Innovative Medicines Initiative
- Call for proposals - Clean Sky Research and Technology Development Projects - 2
Explore other programmes
